Intrinsic mechanisms of neuronal axon regeneration

M Mahar, V Cavalli - Nature Reviews Neuroscience, 2018 - nature.com
Permanent disabilities following CNS injuries result from the failure of injured axons to
regenerate and rebuild functional connections with their original targets. By contrast, injury …

Advances in molecular therapies for targeting pathophysiology in spinal cord injury

HN Kim, MR McCrea, S Li - Expert opinion on therapeutic targets, 2023 - Taylor & Francis
Introduction Spinal cord injury (SCI) affects 25,000–50,000 people around the world each
year and there is no cure for SCI patients currently. The primary injury damages spinal cord …

NAD+, Axonal Maintenance, and Neurological Disease

AS Alexandris, VE Koliatsos - Antioxidants & Redox Signaling, 2023 - liebertpub.com
Significance: The remarkable geometry of the axon exposes it to unique challenges for
survival and maintenance. Axonal degeneration is a feature of peripheral neuropathies …

Metabolic vulnerability in the neurodegenerative disease glaucoma

DM Inman, M Harun-Or-Rashid - Frontiers in Neuroscience, 2017 - frontiersin.org
Axons can be several orders of magnitude longer than neural somas, presenting logistical
difficulties in cargo trafficking and structural maintenance. Keeping the axon compartment …

Functional genome-wide screen identifies pathways restricting central nervous system axonal regeneration

Y Sekine, A Lin-Moore, DM Chenette, X Wang, Z Jiang… - Cell reports, 2018 - cell.com
Axonal regrowth is crucial for recovery from CNS injury but is severely restricted in adult
mammals. We used a genome-wide loss-of-function screen for factors limiting axonal …

Oxidative DNA damage in the pathophysiology of spinal cord injury: seems obvious, but where is the evidence?

EEM Scheijen, S Hendrix, DM Wilson III - Antioxidants, 2022 - mdpi.com
Oxidative stress occurs at various phases of spinal cord injury (SCI), promoting detrimental
processes such as free radical injury of proteins, nucleic acids, lipids, cytoskeleton, and …

Role of ABT888, a novel poly (ADP-ribose) polymerase (PARP) inhibitor in countering autophagy and apoptotic processes associated to spinal cord injury

G Casili, M Campolo, M Lanza, A Filippone… - Molecular …, 2020 - Springer
Accidents are the cause of some 50 deaths per 100,000 population each year; some 3% of
these are from traumatic spinal cord injury (SCI), a damage that causes temporary or …

The Atr-Chek1 pathway inhibits axon regeneration in response to Piezo-dependent mechanosensation

F Li, TY Lo, L Miles, Q Wang, HN Noristani, D Li… - Nature …, 2021 - nature.com
Atr is a serine/threonine kinase, known to sense single-stranded DNA breaks and activate
the DNA damage checkpoint by phosphorylating Chek1, which inhibits Cdc25, causing cell …

Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy

PM LoCoco, AL Risinger, HR Smith, TS Chavera… - Elife, 2017 - elifesciences.org
Chemotherapy-induced peripheral neuropathy (CIPN) arises from collateral damage to
peripheral afferent sensory neurons by anticancer pharmacotherapy, leading to debilitating …

Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting

Y Wang, D Pleasure, W Deng, F Guo - Advanced Science, 2022 - Wiley Online Library
Abstract Poly (ADP‐ribose) polymerase 1 (PARP1) plays a fundamental role in DNA repair
and gene expression. Excessive PARP1 hyperactivation, however, has been associated …